A Green, Scalable, and Catalyst-Free One-Minute Synthesis of Quinoxalines

Vijayaragavan Elumalai; Jørn H. Hansen

doi:10.1055/s-0040-1706021

SynOpen, Table of Contents

CC BY-NC-ND 4.0 · SynOpen 2021; 05(01): 43-48
DOI: 10.1055/s-0040-1706021

letter

A Green, Scalable, and Catalyst-Free One-Minute Synthesis of Quinoxalines

Authors

Vijayaragavan Elumalai
Jørn H. Hansen ∗

Abstract

All articles of this category

Abstract

A highly efficient and catalyst-free protocol is reported for the synthesis of quinoxalines via the classical cyclocondensation reaction between aryldiamines and dicarbonyl compounds. Remarkably simple and green reaction conditions employing methanol as solvent afforded medium to excellent yield of quinoxalines after only one-minute reaction time at ambient temperature. The conditions allow at least 10 gram scale synthesis of quinoxalines and should be a preferred starting point for optimization and method of choice for applications in the synthetic community.

Key words

quinoxaline - diamine - condensation - diketone - green

Full Text

References

References and Notes

1a Gazit A, App H, McMahon G, Chen J, Levitzki A, Bohmer FD. J. Med. Chem. 1996; 39: 2170
1b Sehlstedt U, Aich P, Bergman J, Vallberg H, Norden B, Graslund A. J. Mol. Biol. 1998; 278: 31

2a Sakata G, Makino K, Kuraswa Y. Heterocycles 1988; 27: 2481
2b He W, Meyers MR, Hanney B, Spada A, Blider G, Galzeinski H, Amin D, Needle S, Page K, Jayyosi Z, Perrone H. Bioorg. Med. Chem. Lett. 2003; 13: 3097
2c Kim YB, Kim Y.-H, Park JY, Kim SK. Bioorg. Med. Chem. Lett. 2004; 14: 541

3a Gao H, Huang K.-C, Yamasaki EF, Chan KK, Chohan L, Snapka RM. Proc. Natl. Acad. Sci. U.S.A. 1999; 96: 12168
3b Cole SP, Bhardwaj G, Gerlach JH. Science 1992; 258: 1650
3c Lawrence DS, Copper JE, Smith CD. J. Med. Chem. 2001; 44: 594
3d Yoo HW, Suh ME, Park SW. J. Med. Chem. 1998; 41: 4716
3e Weng Q, Wang D, Guo P. Eur. J. Pharmacol. 2008; 581: 262

4a Tandon VK, Yadav DB, Maurya HK, Chaturvedi AK, Shukla PK. J. Med. Chem. 2006; 14: 6120
4b Carta A, Loriga M, Paglietti G. Eur. J. Med. Chem. 2004; 39: 195

5a Fonseca T, Gigante B, Marques MM, Gilchrist TL, De Clercq E. Bioorg. Med. Chem. 2004; 12: 103
5b Ali I, Al-Masoudi I, Hassan HG, Al-Masoudi N. Chem. Heterocycl. Compd. 2007; 43: 1052

6a Crowther AF, Curd FH.S, Davey DG, Stacey GJ. J. Chem. Soc. 1949; 1260
6b Rangisetty JB, Gupta CN. V. H. B, Prasad AL, Srinivas P, Sridhar N, Parimoo P, Veeranjaneyulu A. J. Pharm. Pharmacol. 2001; 53: 1409

7a Kotharkar SA, Shinde DB. Bioorg. Med. Chem. Lett. 2006; 16: 6181
7b Mashevskaya IV, Makhmudov RR, Aleksandrova GA, Golovnira OV, Duvalov AV, Maslivets AN. Pharm. Chem. J. 2001; 35: 196
7c Vyas DA, Chauhan NA, Parikh AR. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 2007; 46: 1699

8 Gao H, Yamasaki EF, Chan KK, Shen LL, Snapka RM. Cancer Res. 2000; 60: 5937

9a Sonawane ND, Rangnekar DW. J. Heterocycl. Chem. 2002; 39: 303
9b Katoh A, Yoshida T, Ohkanda J. Heterocycles 2000; 52: 911

10a Dailey S, Feast WJ, Peace RJ, Sage IC, Till S, Wood EL. J. Mater. Chem. 2001; 11: 2238
10b Brien D, Weaver MS, Lidzey DG, Bradley DD. C. Appl. Phys. Lett. 1996; 69: 881

11 Sessler JL, Maeda H, Mizuno T, Lynch VM, Furuta H. Chem. Commun. 2002; 862
12 Ott S, Faust R. Synlett 2004; 1509

13a Sessler JL, Maeda H, Mizuno T, Lynch VM, Furuta H. J. Am. Chem. Soc. 2002; 124: 13474
13b Castro PP, Zhao G, Masangkay GA, Hernandez C, Gutierrez-Tunstad LM. Org. Lett. 2004; 6: 333

14 Thomas KR. J, Velusamy M, Lin JT, Chuen C.-H, Tao Y.-T. Chem. Mater. 2005; 17: 1860

15a Kazunobu T, Ryusuke T, Tomohiro O, Shuichi M. Chem. Commun. 2002; 212
15b Hegedus LS, Greenberg MM, Wendling JJ, Bullock JP. J. Org. Chem. 2003; 68: 4179

16a Raw SA, Wilfred CD, Taylor RJ. K. Org. Biomol. Chem. 2004; 2: 788
16b Dell A, William DH, Morris HR, Smith GA, Feeney J, Roberts GC. K. J. Am. Chem. Soc. 1975; 97: 2497
16c Bailly C, Echepare S, Gago F, Waring M. J. Anti-Cancer Drug Des. 1999; 15: 291

For some recent overviews, see:

17a Abu-Hashem AA. Am. J. Org. Chem. 2015; 5: 14
17b Mamedov VA. In Quinoxalines 2016; 5

For some historical references to the imine formation reaction, see:

17c von Pechmann H. Ber. Dtsch. Chem. Ges. 1888; 21: 1411
17d Zincke T, Schmidt M. Justus Liebigs Ann. Chem. 1895; 286: 43

18a Brown DJ. In The Chemistry of Heterocyclic Compounds, Quinoxalines, Suppl. II. Taylor EC. Wiley; Hoboken: 2004
18b More SV, Sastry MN. V, Yao C.-F. Green Chem. 2006; 8: 91
18c Ajaikumar S, Pandurangan A. Appl. Catal., A 2009; 357: 184
18d Liu J.-Y, Liu J, Wang J.-D, Jiao D.-Q, Liu H.-W. Synth. Commun. 2010; 40: 2047
18e Kumbhar A, Kamble S, Barge M, Rashinkar G, Salunkhe R. Tetrahedron Lett. 2012; 53: 2756
18f Kadam HK, Khan S, Kunkalkar RA, Tilve SG. Tetrahedron Lett. 2013; 54: 1003
18g Arde SM, Patil AD, Mane AH, Salokhe PR, Salunkhe RS. Res. Chem. Intermed. 2020; 46: 5069

For an example of a reaction in refluxing methanol without other additives, see:

18h Rewcastle GW, Denny WA, Baguley BC. J. Med. Chem. 1987; 30: 843

19a Cho CS, Oh SG. Tetrahedron Lett. 2006; 47: 5633
19b Bera A, Sk M, Singh K, Banerjee D. Chem. Commun. 2019; 55: 5958
19c Daw P, Kumar A, Espinosa-Jalapa NA, Posner YD, David YB, Milstein D. ACS Catal. 2018; 8: 7734
19d Shee S, Ganguli K, Jana K, Kundu S. Chem. Commun. 2018; 54: 6883
19e Hille T, Irrgang T, Kempe R. Chem. Eur. J. 2014; 20: 5569
19f Mondal A, Sahoo MK, Subaramanian M, Balaraman E. J. Org. Chem. 2020; 85: 7181

20a Raw SA, Wilfred CD, Taylor RJ. K. Chem. Commun. 2003; 2286
20b Raw SA, Wilfred CD, Taylor RJ. K. Org. Biomol. Chem. 2004; 2: 788
20c Kim SY, Park KH, Chung YK. Chem. Commun. 2005; 1321
20d Cho CS, Oh SG. J. Mol. Catal. A.: Chem. 2007; 276: 205

21 Das B, Venkateswarlu K, Suneel K, Majhi A. Tetrahedron Lett. 2007; 48: 5371

22a Wan JP, Gan S.-F, Wu J.-M, Pan Y.-J. Green Chem. 2009; 11: 1633
22b Villemin D, Martin B. Synth. Commun. 1995; 25: 2319
22c Juncai F, Yang L, Qinghua M, Bin L. Synth. Commun. 1998; 28: 193
22d Vázquez E, De La Hoz A, Elander N, Moreno A, Stone-Elander S. Heterocycles 2001; 55: 109
22e Goswami S, Adak AK. Tetrahedron Lett. 2002; 43: 8371
22f Zhao Z, Wisnoski DD, Wolkenberg SE, Leister WH, Wang Y, Lindsley CW. Tetrahedron Lett. 2004; 45: 4873
22g Kim SY, Park KH, Chung YK. Chem. Commun. 2005; 1321
22h Kidwai M, Saxena S, Mohan R. J. Korean Chem. Soc. 2005; 49: 288
22i Azizian J, Karimi AR, Kazemizadeh Z, Mohammadi AA, Mohammadizadeh MR. Tetrahedron Lett. 2005; 46: 6155
22j Gris J, Glisoni R, Fabian L, Fernández B, Moglioni AG. Tetrahedron Lett. 2008; 49: 1053

23 Wu Z, Ede NJ. Tetrahedron Lett. 2001; 42: 8115
24 Sadjadi S, Sadjadi S, Hekmatshoar R. Ultrason. Sonochem. 2010; 17: 764

25a Jafarpour M, Rezaeifard A, Danehchin M. Appl. Catal. A 2011; 394: 48
25b Zhou JF, Gong GX, Shi KB, Zhi SJ. Chin. Chem. Lett. 2009; 20: 672
25c Krishnakumar B, Velmurugan R, Jothivel S, Swaminathan M. Catal. Commun. 2010; 11: 997
25d Niknam K, Saberi D, Mohagheghnejad M. Molecules 2009; 14: 1915
25e Darabi HR, Mohandessi S, Aghapoor K, Mohsenzadeh F. Catal. Commun. 2007; 8: 389

26 More SV, Sastry MN. V, Wang CC, Ching-Fa Y. Tetrahedron Lett. 2005; 46: 6345
27 Islami MR, Hassani Z. ARKIVOC 2008; (xv): 280
28 Bhosale RS, Sarda SR, Ardhapure SS, Jadhav WN, Bhusare SR, Pawar RP. Tetrahedron Lett. 2005; 46: 7183
29 Kumar A, Kumar S, Saxena A, De A, Mozumdar S. Catal. Commun. 2008; 9: 778
30 Dong F, Gong K, Fei Z, Zhou X, Liu Z. Catal. Commun. 2008; 9: 317
31 Darabi HR, Tahoori F, Aghapoor K, Taala F, Mohsenzadeh F. J. Braz. Chem. Soc. 2008; 19: 1646
32 Jafarpour M, Rezaeifard A, Danehchin M. Appl. Catal. A 2011; 394: 48
33 Raw SA, Wilfred CD, Taylor RJ. K. Org. Biomol. Chem. 2004; 2: 788
34 Venkatesh C, Singh B, Mahata PK, IIa H, Junjappa H. Org. Lett. 2005; 7: 2169
35 Brown DJ. Quinoxalines . In The Chemistry of Heterocyclic Compounds, Vol. 61 . Taylor EC, Wipf P. John Wiley & Sons; Hoboken: 2004: 1
36 More SV, Sastry MN. V, Yao CF. Green Chem. 2006; 8: 91
37 Cai JJ, Zou JP, Pan XQ, Zhang W. Tetrahedron Lett. 2008; 49: 7386
38 Heravi MM, Taheri S, Bakhtiari K, Oskooie HA. Catal. Commun. 2007; 8: 211
39 Darabi HR, Mohandessi S, Aghapoor K, Mohsenzadeh F. Catal. Commun. 2007; 8: 389
40 Elumalai V, Hansen JH. Synlett 2020; 31: 547
41 Typical ProcedureIn a 25 mL round-bottom flask was added benzene-1,2-diamine (1a, 100 mg, 0.925 mmol) which was dissolved in MeOH (5 mL). To the stirred solution, glyoxal (2a, 40%, 134 mg, 0.11 mL, 0.925 mmol) was added and the mixture stirred for 1 min at ambient temperature, followed by quenching with water (10 mL), dilution with ethyl acetate (50 mL), and washing with water (30 mL). The water layer was extracted with ethyl acetate (2 × 30 mL), the organic layers were combined, and dried over anhydrous Na₂SO₄. The drying agent was removed by filtration, and the solvent was evaporated under reduced pressure to obtain the desired product 3a as a yellowish liquid (0.111 g, 93%) without column purification (GC purity >99%). ¹H NMR (400 MHz, CDCl₃): δ = 8.84 (s, 2 H), 8.11 (dd, J = 6.4, 3.5 Hz, 2 H), 7.78 (dd, J = 6.4, 3.5 Hz, 2 H). ¹³C NMR (101 MHz, CDCl₃): δ = 145.0, 143.1, 130.1, 129.5.From 1-gram-scale SynthesisCompound 3w was obtained as golden-yellow solid (1.710 g, 94%) without column purification (GC purity >99%). ¹H NMR (400 MHz, CDCl₃): δ = 8.51 (d, J = 1.9 Hz, 1 H), 8.33–8.21 (m, 4 H), 7.95 (dt, J = 7.8, 1.1 Hz, 1 H), 7.89–7.80 (m, 3 H), 7.75 (dtd, J = 13.2, 7.7, 1.8 Hz, 2 H), 7.60–7.51 (m, 1 H), 7.48–7.41 (m, 2 H), 7.18 (dddd, J = 7.7, 6.3, 5.1, 1.2 Hz, 2 H). ¹³C NMR (101 MHz, CDCl₃): δ = 195.7, 157.1, 157.0, 154.1, 153.6, 148.7, 148.7, 142.9, 140.2, 138.8, 137.1, 136.8, 136.8, 132.9, 132.5, 130.4, 130.2, 129.9, 128.6, 124.4, 124.2, 123.4, 123.3.
42 Although there are only 3 novel compounds produced in this study, we have provided the NMR spectra for all entries in order to demonstrate the purity of the products after the indicated procedure. These can be found in the Supporting Information.

Supplementary Material

Supporting Information (PDF)